Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

Background: Hypertensive cerebral small vessel disease (HT-CSVD) is a cerebrovascular clinical, imaging and pathological syndrome caused by hypertension (HT). The condition manifests with lesions in various vessels including intracranial small/arterioles, capillaries, and small/venules. Hypertensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Rui, Hu, Hua, Zhou, Yue, Wang, Shanshan, Mei, Zhigang, She, Ruining, Peng, Xiwen, Jiang, Qiling, Wang, Xiangyuan, Xie, Le, Lin, Hongyuan, Meng, Pan, Zhang, Kun, Wang, Wei, Xie, Yao, Liu, Litao, Tong, Jiao, Wu, Dahua, Luo, Yunhua, Liu, Chang, Lu, Yifang, Yu, Shangzhen, Cheng, Shaowu, Xu, Linyong, Fang, Zhuyuan, Shang, Hongcai, Ge, Jinwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853990/
https://www.ncbi.nlm.nih.gov/pubmed/36686705
http://dx.doi.org/10.3389/fphar.2022.967457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853990/
https://www.ncbi.nlm.nih.gov/pubmed/36686705
http://dx.doi.org/10.3389/fphar.2022.967457

Ejemplares similares